Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fromont

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 29, 2011
[High-risk prostate cancer. Review by the Oncology Committee of the French Urology Association]F Rozet, C Hennequin, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 27, 2012
[Lymphadenectomy and prostate cancer: a statement of the committee of cancerology of the French Association of Urology]L Salomon, M Peyromaure, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 23, 2018
[French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017]F Rozet, C Hennequin, P Mongiat-Artus, et al.
British Journal of Cancer|July 29, 2004
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursorsI Rehman, S S Cross, A-R Azzouzi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2014
[Management of low-risk prostate cancer]F Rozet, C Bastide, P Beuzeboc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 12, 2010
[T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU)]B Faivre d'Arcier, O Celhay, A Safsaf, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 18, 2015
[Imagery of treated prostate cancer]R Renard-Penna, L Michaud, L Cormier, et al.
Journal of Medical Genetics|July 6, 2004
Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinomaM Roupret, J Catto, F Coulet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 11, 2020
[French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020]F Rozet, C Hennequin, P Beuzeboc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2013
[Prostate brachytherapy: indications and outcomes]C Hennequin, L Cormier, P Richaud, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 29, 2011
[High-risk prostate cancer. Review by the Oncology Committee of the French Urology Association]F Rozet, C Hennequin, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 27, 2012
[Lymphadenectomy and prostate cancer: a statement of the committee of cancerology of the French Association of Urology]L Salomon, M Peyromaure, G Fromont, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 23, 2018
[French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017]F Rozet, C Hennequin, P Mongiat-Artus, et al.
British Journal of Cancer|July 29, 2004
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursorsI Rehman, S S Cross, A-R Azzouzi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2014
[Management of low-risk prostate cancer]F Rozet, C Bastide, P Beuzeboc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 12, 2010
[T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU)]B Faivre d'Arcier, O Celhay, A Safsaf, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 18, 2015
[Imagery of treated prostate cancer]R Renard-Penna, L Michaud, L Cormier, et al.
Journal of Medical Genetics|July 6, 2004
Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinomaM Roupret, J Catto, F Coulet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 11, 2020
[French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020]F Rozet, C Hennequin, P Beuzeboc, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2013
[Prostate brachytherapy: indications and outcomes]C Hennequin, L Cormier, P Richaud, et al.
Pageof 10